ADD/ADHD News

Adolescents and young adults with ADHD were at higher risk for STIs later in life compared with those without the disorder; however, ADHD medications may reduce this risk, by as much as 41% in men, according to researchers in Taiwan.

Children of men who used selective serotonin reuptake inhibitors before conception are 26% more likely to develop attention-deficit/hyperactivity disorder later in life, according to findings published in Pediatrics.

Recent findings showed differences in how individuals with ADHD used social media, compared with peers without ADHD.

Sunovion Pharmaceuticals Inc. recently announced the FDA accepted for review a New Drug Application for dasotraline, a novel-acting dopamine and norepinephrine reuptake inhibitor, for treatment of ADHD in children and adults.

Although short-term use of acetaminophen for pregnant women was not associated with a future ADHD diagnosis in their offspring, long-term maternal use of the drug for fever and infection results in a more than two-fold increase in the likelihood of their children developing the condition.

Data presented at the American Academy of Child and Adolescent Psychiatry annual meeting indicated efficacy of monotherapy external trigeminal nerve stimulation for ADHD in children.

Children with a younger relative age were more likely to be diagnosed with ADHD in a health service system with low prescribing rates for ADHD.

Children with ADHD exhibited poorer tactile functioning, including reaction time and detection threshold, compared with typically developing children.

ADHD may primarily be a problem associated with abnormal circadian sleep, according to an expert at the European College of Neuropsychopharmacology Congress.

ADHD symptom type and gender influenced risk for smoking, according to recent findings that indicated greater association between ADHD and smoking outcomes in females.